Kaibara N, Nishimura O, Nishidoi H, Kimura O, Koga S
First Department of Surgery, Tottori University School of Medicine, Japan.
J Surg Oncol. 1987 Oct;36(2):110-2. doi: 10.1002/jso.2930360207.
To assess the efficacy of proximal gastrectomy in the treatment of upper gastric carcinoma, we analyzed clinical data from patients with lesions confined to the upper third of the stomach (group 1) and from patients with lesions which, while primarily located in the upper portion of the stomach, showed spread to the body of the stomach (group 2). Patients in group 2 showed more metastatic lymph node involvement, particularly of the infrapyloric lymph nodes, which were not included in lymphadenectomy accompanying proximal gastrectomy. None of the group 1 patients demonstrated metastasis to the infrapyloric lymph nodes. The postoperative 5-year survival rate in curatively operated group 1 patients was not significantly different between those treated by proximal gastrectomy and those subjected to total gastrectomy. We conclude that proximal gastrectomy is indicated in patients with upper gastric carcinoma when it is confined to the upper third of the stomach.
为评估近端胃切除术治疗胃上部癌的疗效,我们分析了病变局限于胃上部三分之一的患者(第1组)以及病变虽主要位于胃上部但已扩散至胃体部的患者(第2组)的临床数据。第2组患者出现更多转移淋巴结受累情况,尤其是幽门下淋巴结,而这些淋巴结并不包含在近端胃切除术所伴随的淋巴结清扫范围内。第1组患者均未出现幽门下淋巴结转移。第1组接受根治性手术的患者中,接受近端胃切除术和全胃切除术的患者术后5年生存率无显著差异。我们得出结论,当胃上部癌局限于胃上部三分之一时,近端胃切除术适用于此类患者。